Home › Coronary Artery Disease › NCT06114615
Digital Monitoring for Patients Post Coronary Interventions to Reduce Risk for Recurrent Adverse Cardiovascular Events
Who can join
All ages · All sexes
Full eligibility criteria
Inclusion Criteria: * Includes patients with coronary heart disease diagnosis and treatment with PCI who follow up at University of California Davis Health.
About the study
The study aims to support patients immediately after percutaneous coronary intervention (PCI) by implementing a telemonitoring program. Eligible patients have coronary heart disease and undergo PCI. The intervention group receives remote monitoring and text-based follow-up, with established health goals and education on using the telemonitoring application, along with necessary devices. The control group gets standard care. Outcomes measured include blood pressure, LDL levels, patient satisfaction, revascularization, and mortality. The study findings will enhance patient care after PCI and contribute evidence for widespread telemonitoring implementation in healthcare systems, aiding medical therapy and lifestyle modifications.
What is being tested
- LiveCare (device)
- Text Messages (behavioral)
- Conventional Care (other)
Sponsor: University of California, Davis · Participants: 200 · Started: Jan 1, 2024
Contact the study team
- Surabhi Atreja, MD · Phone: (916) 734-2011
Official record on ClinicalTrials.gov — NCT06114615
Locations in the U.S.
| California | University of California, Davis Medical Center Division of Cardiovascular Medicine, Sacramento |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.